Rituximab for psychotic disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jul 2023: Trial registered, NCT05946486

The trials

NCT05946486: Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

State
Not started
Phase
Phase 3
People
174 planned
Started
15 Oct 2023
Primary completion
15 Jan 2026
Arms
experimental group
Results
None posted
  1. 14 Jul 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Also known as Rituxan hycela component rituximab.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.